Kullanım Kılavuzu
Neden sadece 3 sonuç görüntüleyebiliyorum?
Sadece üye olan kurumların ağından bağlandığınız da tüm sonuçları görüntüleyebilirsiniz. Üye olmayan kurumlar için kurum yetkililerinin başvurması durumunda 1 aylık ücretsiz deneme sürümü açmaktayız.
Benim olmayan çok sonuç geliyor?
Birçok kaynakça da atıflar "Soyad, İ" olarak gösterildiği için özellikle Soyad ve isminin baş harfi aynı olan akademisyenlerin atıfları zaman zaman karışabilmektedir. Bu sorun tüm dünyadaki atıf dizinlerinin sıkça karşılaştığı bir sorundur.
Sadece ilgili makaleme yapılan atıfları nasıl görebilirim?
Makalenizin ismini arattıktan sonra detaylar kısmına bastığınız anda seçtiğiniz makaleye yapılan atıfları görebilirsiniz.
 Görüntüleme 8
 İndirme 2
Kardiyopulmoner Bypass Esnasında Antikoagülan Kullanımı Mikrotrombüs Oluşumunu Tam Olarak Engelliyor mu?
2018
Dergi:  
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Yazar:  
Özet:

Aim:  This study examined whether heparin use during cardiopulmonary bypass (CBP) completely prevents microthrombus formation. Materials and Methods: The coagulation systems of 42 patients undergoing open heart surgery were evaluated by collecting blood specimens for factor (F) II, V, VII, and X, antithrombin-III (AT-III), protein C, protein S, fibrinogen, D-dimer, PT, aPTT and complete blood count investigation before induction of anesthesia, half an hour after start of CBP, following sternum closure and on postoperative day 1. Liver, kidney and neurocognitive functions were also evaluated. Results: FII, FV, FVII, FX, AT-III and protein C values decreased significantly during CBP compared to preoperative values, and then gradually increased. Protein S values increased significantly during CBP and subsequently decreased to preoperative levels. Fibrinogen levels fluctuated, while D-dimer, PT ve aPTT increased during CBP. Hemoglobin, hematocrit and platelet values also decreased during CBP, and then rose gradually. No significant kidney, liver or neurocognitive function impairment was determined. Conclusion: Coagulation factors decreasing during CBP and then rising may be related to hemodilution. However, the increase in D-dimer shows that thrombus formation occurs during CBP, although this is not clinically significant

Anahtar Kelimeler:

Does the use of anticoagulant during the cardiopulmonary bypass completely prevent the formation of microtrombus?
2018
Yazar:  
Özet:

This study examined whether heparin use during cardiopulmonary bypass (CBP) completely prevents microthrombus formation. Materials and Methods: The coagulation systems of 42 patients undergoing open heart surgery were evaluated by collecting blood specimens for factor (F) II, V, VII, and X, antithrombin-III (AT-III), protein C, protein S, fibrinogen, D-dimer, PT, aPTT and complete blood count investigation before induction of anesthesia, half an hour after the start of CBP, following sternum closure and on postoperative day 1. Liver, kidney and neurocognitive functions were also evaluated. Results: FII, FV, FVII, FX, AT-III and protein C values decreased significantly during CBP compared to preoperative values, and then gradually increased. Protein S values increased significantly during CBP and subsequently decreased to preoperative levels. Fibrinogen levels fluctuated, while D-dimer, PT and aPTT increased during CBP. Hemoglobin, hematocrit and platelet values also decreased during CBP, and then rose gradually. No significant kidney, liver or neurocognitive function disorder was determined. Conclusion: Coagulation factors decreasing during CBP and then rising may be related to hemodilution. However, the increase in D-dimer shows that thrombus formation occurs during CBP, although this is not clinically significant

Anahtar Kelimeler:

Atıf Yapanlar
Bilgi: Bu yayına herhangi bir atıf yapılmamıştır.
Benzer Makaleler










Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi

Alan :   Sağlık Bilimleri

Dergi Türü :   Uluslararası

Metrikler
Makale : 436
Atıf : 175
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi